Eckert & Ziegler Finalizes Take Over Bid IBt
Change in the Management of IBt Bebig
Payment of the consideration for the IBt shares, IBt beneficiary shares B and IBt warrants shall be made by the receiving and paying agent KBC Securities, on 7 April 2010, directly to the beneficiaries or via their financial institution.
IBt Bebig also announced today that the CEO, Mr François Blondel, and the Company have decided to end their collaboration. As a result, Mr François Blondel will resign, with immediate effect, from all of his duties and responsibilities within the Group, whether as a Director of IBt s.a. or of its subsidiaries.
Dr. Edgar Löffler and Dr. Gunnar Mann, directors of IBt, have been appointed as the new persons in charge of the daily management of the company. They will take over the responsibilities of Mr. Blondel and manage IBt jointly, each in his capacity as Managing Director.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.